When a supplier states that a research peptide is "≥98% pure", that figure almost always comes from one technique: reverse-phase high-performance liquid chromatography, or RP-HPLC. It is the workhorse of peptide quality control because it is precise, reproducible and sensitive to the impurities that peptide synthesis typically produces.
This guide explains how the method works, how to read the chromatogram behind a purity figure, and — just as importantly — what HPLC cannot tell you on its own.
How reverse-phase HPLC separates a peptide sample
In RP-HPLC, a dissolved sample is pumped through a column packed with tiny particles coated in a water-repelling (hydrophobic) layer — most commonly C18 chains. Peptides stick to that layer to different degrees depending on their hydrophobicity.
The mobile phase starts mostly aqueous and is gradually made richer in an organic solvent, usually acetonitrile, with a small amount of an acid modifier such as trifluoroacetic acid (TFA). As the organic proportion rises, molecules let go of the column one after another. Molecules that differ only slightly — a missing amino acid, an oxidised residue — tend to leave at slightly different times.
A UV detector at the column outlet records the signal over time. Peptide bonds absorb strongly at around 214–220 nm, which is why that wavelength range is typical for peptide purity methods.
Reading a chromatogram
The output is a chromatogram: signal on the vertical axis, time on the horizontal axis. On a good peptide batch you will see:
- One dominant peak — the target peptide — at a characteristic retention time.
- Small impurity peaks before and after it.
- A flat baseline between peaks.
Software integrates the area under each peak. Purity is the main peak's area divided by the total area of all integrated peaks, expressed as a percentage. A result of 98.7% means 1.3% of the detected signal belongs to other components.
When you review a chromatogram, check that the main peak is sharp and symmetrical, that impurity peaks are small and well separated, and that the integration report lists the peaks rather than showing a single unexplained number.
What the impurity peaks usually are
Solid-phase peptide synthesis builds a chain one amino acid at a time, and no coupling step is perfectly efficient. Typical peptide-related impurities include:
- Deletion sequences — chains missing one amino acid because a coupling step failed.
- Truncated sequences — chains that stopped growing early.
- Oxidation products — especially at methionine, cysteine or tryptophan residues.
- Deamidation products — asparagine or glutamine converted to their acidic forms.
- Incomplete deprotection — protecting groups left attached after synthesis.
Purification removes most of these; the HPLC purity figure tells you how much remains.
What HPLC cannot tell you on its own
HPLC purity is essential, but it has limits that every buyer should understand.
| Question | Answered by HPLC-UV? | Complementary method |
|---|---|---|
| How clean is the sample relative to related impurities? | Yes | — |
| Is the main peak the correct molecule? | Not on its own | Mass spectrometry (LC-MS) |
| How much of the powder mass is peptide? | No | Peptide content / amino acid analysis |
| How much water does the powder contain? | No | Karl Fischer titration |
| Are there impurities that do not absorb UV at the test wavelength? | Not reliably | Orthogonal methods (e.g. MS) |
In particular:
- Identity. A clean single peak proves the sample is homogeneous, not that it is the right compound. Identity is normally confirmed by mass spectrometry, which compares the measured molecular mass with the theoretical value — roughly 4731 g/mol for retatrutide, for example.
- Net peptide content. Lyophilised peptides contain water and counter-ions (such as TFA or acetate salts) that HPLC-UV does not count. A sample can be 99% pure and still be noticeably less than 100% peptide by mass. Our CoA guide covers this distinction in more detail.
- Co-elution. Two different molecules can occasionally leave the column at the same time and appear as a single peak. Method development and orthogonal testing reduce that risk.
Questions to ask a supplier about purity data
- Which method and detection wavelength were used?
- Can I see the chromatogram and peak integration report for my batch?
- How was identity confirmed for this batch?
- Is the purity result batch-specific, or a typical value?
- Was peptide content or water content measured?
A supplier with a working quality system will answer these without difficulty.
How Peptide Direct applies HPLC testing
Every compound we supply — from BPC-157 and TB-500 to Ipamorelin — is verified by HPLC to a minimum purity of ≥98% on a batch-by-batch basis before dispatch, and every order ships with a batch Certificate of Analysis referencing the method used. Full batch-level HPLC reports are available on request as part of our quality assurance documentation.